Chronic Li+ attenuates agonist- and phorbol ester-mediated Na+/H+ antiporter activity in HL-60 cells-Reference-Cited by-同舟云学术

Chronic Li+ attenuates agonist- and phorbol ester-mediated Na+/H+ antiporter activity in HL-60 cells

Published:1990-04 Issue:4-5 Volume:188 Page:193-202
ISSN:0922-4106
Container-title:European Journal of Pharmacology: Molecular Pharmacology
language:en
Short-container-title:European Journal of Pharmacology: Molecular Pharmacology

Author:

Bitran Jose A.,Potter William Z.,Manji Husseini K.,Gusovsky Fabian

Publisher

Elsevier BV

Subject

Pharmacology

Reference41 articles.

1. Increased brain myo-inositol 1-phosphate in lithium-treated rats;Allison;Biochem. Biophys. Res. Commun.,1976

2. Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate;Ballester;J. Biol. Chem.,1985

3. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor;Benovic,1986

4. Inositol triphosphate and diacylgycerol: two interacting second messinger;Berridge;Annu. Rev. Biochem.,1987

5. Amiloride inhibits phorbol ester-stimulated Na+/H+ exchange and protein kinase C. An amiloride analog selectivity inhibits N+/H+ exchange;Besterman;J. Biol. Chem.,1985

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posttranslational modifications & lithium’s therapeutic effect—Potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders;Neuroscience & Biobehavioral Reviews;2021-08

2. Evidence of nigericin as a potential therapeutic candidate for cancers: A review;Biomedicine & Pharmacotherapy;2021-05

3. NOX2-Dependent Reactive Oxygen Species Regulate Formyl-Peptide Receptor 1-Mediated TrkA Transactivation in SH-SY5Y Cells;Oxidative Medicine and Cellular Longevity;2019-12-02

4. Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature;Molecular Neuropsychiatry;2017

5. Tamoxifen use for the management of mania: a review of current preclinical evidence;Psychopharmacology;2014-01-18